Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - OTHER CURRENT ASSETS
Other Current Assets PRPH - ProPhase Labs, Inc.
2.7 M
LAST VALUE
24.24%
2 YEAR CAGR
55.54%
5 YEAR CAGR
-1.39%
10 YEAR CAGR